Paper Review Records
All Paper Review Records
25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Aromatase inhibitors versus tamoxifen and the risk of incident intracranial meningioma: a propensity score matching analysis of 46,408 patients
Jeremiah Hilkiah Wijaya; Soni Roy Kurniawan Hulu; Brandon Lucke-Wold; Made Agus Mahendra Inggas; Vivien PuspitasariShow moreShow less
1. Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, USA; 2. School of Nursing, College of Nursing, Taipei Medical University, Taipei, Taiwan; 3. Department of Neurosurgery, University of Arizona College of Medicine, Tucson, USA; 4. Neurosurgical Department, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, Indonesia; 5. Neurology Department, Faculty of Medicine, Universitas Pelita Harapan, Tangerang, IndonesiaShow moreShow less
Participation in the German mammography screening program: about 70% of women participate at least once between age 50 and 60
Miriam Heinig; Laura Buschmann; Florian Oesterling; Bianca Kollhorst; Jonas Czwikla; Heike Minnerup; André Karch; Ulrike HaugShow moreShow less
1. Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology–BIPS, Bremen, Germany; 2. Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany; 3. Cancer Registry North Rhine-Westphalia, Bochum, Germany; 4. Department of Statistical Methods in Epidemiology, Leibniz Institute for Prevention Research and Epidemiology–BIPS, Bremen, Germany; 5. Institute for Clinical Epidemiology and Biometry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany; 6. Faculty of Human and Health Sciences, University of Bremen, Bremen, GermanyShow moreShow less
U.S. state-level variation in caregiver-reported provider recommendation of HPV vaccination to 13-to-17-year-old adolescents
Chinenye Lynette Ejezie; Chengcheng Zhang; Nada Eldawy; Ming Li; Paula CuccaroShow moreShow less
1. Towson University, Towson, USA; 2. Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, USA; 3. UTHealth Houston School of Public Health, Houston, USAShow moreShow less
Body composition and risks of head and neck cancers: evidence from a large-scale population-based cohort
Junhong Li; Baofei Li; Ke Qiu; Di Deng; Danni Cheng; Wendu Pang; Yao Song; Yufang Rao; Yu Zhao; Jianjun RenShow moreShow less
1. Department of Otolaryngology-Head & Neck Surgery, and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, P.R. ChinaShow moreShow less
Metagenomic evidence for persistent gut colonization of colibactin-producing Escherichia coli in colorectal cancer patients
Flemming Damgaard; Ulrik S. JustesenShow moreShow less
1. Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark; 2. Department of Clinical Research, Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark; 3. Department of Biochemistry and Molecular Biology, Faculty of Natural Sciences, University of Southern Denmark, Odense, DenmarkShow moreShow less
Leveraging claims data-based small-area estimation to evaluate endoscopy access and the area-level prevalence of being up-to-date with colorectal cancer screening among screen-eligible adults in North Carolina
Arrianna Marie Planey; Bradford E. Jackson; Tzy-Mey Kuo; Brian J. Reich; Stephanie B. Wheeler; Daniel S. Reuland; Anisha P. Ganguly; Christopher D. Baggett; Jennifer L. Lund; Katie Reeder-HayesShow moreShow less
1. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA; 2. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, USA; 3. Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, USA; 4. Department of Statistics, North Carolina State University, Raleigh, USA; 5. Division of General Medicine and Clinical Epidemiology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA; 6. Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA; 7. Division of Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USAShow moreShow less
FAQ
How long does CANCER CAUSES & CONTROL take to review a manuscript?
As of 2026-11-19, CrushSCI has 25 complete review records for CANCER CAUSES & CONTROL. The fastest paper went from submission to acceptance in 23 days (Aromatase inhibitors versus tamoxifen and the risk of incident intracranial meningioma: a propensity score matching analysis of 46,408 patients, received 2026-10-06, accepted 2026-10-29); the slowest took 326 days. The average is 125.8 days and the median is 107 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
